Showing results (1731-1740 of 3,794) with videos related to

Sort By:
Pageof 380
Oncoimmunology|September 14, 2016
Chemotherapy and immunotherapy: A close interplay to fight cancer?Aurélie Hanoteau, Muriel Moser
Oncoimmunology|September 14, 2016
Tertiary lymphoid structures are confined to patients presenting with unifocal Langerhans Cell HistiocytosisWillemijn T Quispel, Eline C Steenwijk, Vincent van Unen, et al.
Oncoimmunology|September 14, 2016
Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapyMasahiro Azuma, Yohei Takeda, Hiroko Nakajima, et al.
Oncoimmunology|September 14, 2016
Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killingConor J Kearney, Kelly M Ramsbottom, Ilia Voskoboinik, et al.
Oncoimmunology|September 14, 2016
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodiesElisa Cappuzzello, Anna Tosi, Paola Zanovello, et al.
Oncoimmunology|September 14, 2016
Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccinationSteve Boudewijns, Rutger H T Koornstra, Harm Westdorp, et al.
Oncoimmunology|September 14, 2016
CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumorsMarina Bacac, Christian Klein, Pablo Umana
Oncoimmunology|April 11, 2018
A targeted immunotherapy approach for HER2/neu transformed tumors by coupling an engineered effector domain with interferon-γHongtao Zhang, Lian Lam, Yasuhiro Nagai, et al.
Oncoimmunology|April 11, 2018
Potentiating tumor immunity using aptamer-targeted RNAi to render CD8+ T cells resistant to TGFβ inhibitionYvonne Puplampu-Dove, Tal Gefen, Anugraha Rajagopalan, et al.
Oncoimmunology|April 11, 2018
OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosisKunlin Xie, Lin Xu, Hao Wu, et al.
Pageof 380